logo
Plus   Neg
Share
Email

Abbott Labs Raises 2019 Outlook

Abbott Laboratories (ABT) raised its full-year 2019 outlook.

Abbott now projects earnings per share from continuing operations to be in the range of $2.06 to $2.12, adjusted earnings per share from continuing operations of $3.21 to $3.27 and organic sales growth of 7.0 to 8.0 percent for the full year 2019. Analysts polled by Thomson Reuters expect the company to report earnings of $3.22 per share for 2019. Analysts' estimates typically exclude special items.

Previously, the company expected earnings per share from continuing operations to be in the range of $1.95 to $2.05, and adjusted earnings per share from continuing operations of $3.15 to $3.25.

For third-quarter 2019, the company expects earnings per share from continuing operations to be in the range of $0.53 to $0.55 and adjusted earnings per share from continuing operations of $0.83 to $0.85. Analysts project third-quarter earnings of $0.85 per share.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Apple Inc. is taking necessary precautions including Covid-19 testing for those employees returning to work at its headquarters in Silicon Valley, Bloomberg reported citing people familiar with the process. The company, which opened its main Apple Park office in May bringing back some hardware and software engineers, plans the gradual reopening of the building keeping the coronavirus safeguards. A U.S. appeals court has blocked the sales of Bayer AG's dicamba-based Xtendimax in the United States. The three-judge panel in the U.S. Court of Appeals for the Ninth Circuit ruled that the US Environmental Protection Agency (EPA) overstated the protections and substantially understated or ignored the risks related to the use of dicamba-based herbicides. Tesla Chief Executive Officer Elon Musk has called for a breakup of Amazon after the online retail giant refused to publish an upcoming book about COVID-19. Writer Alex Berenson said on Twitter that Amazon refused to publish his booklet about the coronavirus as it did not comply with the company's guidelines. Berenson is a former New York Times reporter.
Follow RTT